These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21320279)

  • 1. Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case-cohort study.
    Karakas M; Baumert J; Herder C; Rottbauer W; Meisinger C; Koenig W; Thorand B
    J Thromb Haemost; 2011 May; 9(5):1078-80. PubMed ID: 21320279
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study.
    Salomaa V; Matei C; Aleksic N; Sansores-Garcia L; Folsom AR; Juneja H; Chambless LE; Wu KK
    Lancet; 1999 May; 353(9166):1729-34. PubMed ID: 10347984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble thrombomodulin and coronary heart disease.
    Wu KK
    Curr Opin Lipidol; 2003 Aug; 14(4):373-5. PubMed ID: 12865735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies.
    Herder C; Peeters W; Illig T; Baumert J; de Kleijn DP; Moll FL; Poschen U; Klopp N; Müller-Nurasyid M; Roden M; Preuss M; ; Karakas M; Meisinger C; Thorand B; Pasterkamp G; Koenig W; Assimes TL; Deloukas P; Erdmann J; Holm H; Kathiresan S; König IR; McPherson R; Reilly MP; Roberts R; Samani NJ; Schunkert H; Stewart AF
    PLoS One; 2011; 6(12):e25734. PubMed ID: 22162987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.
    Morange PE; Simon C; Alessi MC; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Juhan-Vague I;
    Circulation; 2004 Mar; 109(11):1343-8. PubMed ID: 15023872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-1998.
    Thorand B; Baumert J; Herder C; Meisinger C; Koenig W
    Diabetologia; 2007 Mar; 50(3):545-8. PubMed ID: 17195062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study.
    Karakas M; Koenig W; Zierer A; Herder C; Rottbauer W; Baumert J; Meisinger C; Thorand B
    J Intern Med; 2012 Jan; 271(1):43-50. PubMed ID: 21535251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Cella G; Randi ML
    Lancet; 1999 Jul; 354(9176):425. PubMed ID: 10437896
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Mennen LI; Amiral J; Guize L; Pujol Y; Scarabin PY
    Lancet; 1999 Jul; 354(9176):425-6. PubMed ID: 10437897
    [No Abstract]   [Full Text] [Related]  

  • 10. Job strain-associated inflammatory burden and long-term risk of coronary events: findings from the MONICA/KORA Augsburg case-cohort study.
    Emeny RT; Zierer A; Lacruz ME; Baumert J; Herder C; Gornitzka G; Koenig W; Thorand B; Ladwig KH;
    Psychosom Med; 2013 Apr; 75(3):317-25. PubMed ID: 23460721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease.
    Blann AD; Amiral J; McCollum CN
    Eur J Haematol; 1997 Aug; 59(2):115-20. PubMed ID: 9293860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of soluble thrombomodulin in the coronary circulation of patients with coronary artery disease].
    Nakagawa I; Matsubara T; Hori T; Imai S; Ozaki K; Mezaki T; Nasuno A; Kubota K; Nakano M; Yamazoe M; Aizawa Y
    J Cardiol; 2001 Sep; 38(3):145-52. PubMed ID: 11577611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin levels in patients with coronary artery disease.
    Mihara H; Murai A; Handa K; Saku K; Shirai K; Tanaka K; Arakawa K
    Artery; 1997; 22(6):293-308. PubMed ID: 9921405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Goldstein MR
    Lancet; 1999 Jul; 354(9176):426. PubMed ID: 10437898
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble thrombomodulin in patients with established atherosclerosis.
    Gerdes VE; Kremer Hovinga JA; Ten Cate H; Brandjes DP; Büller HR;
    J Thromb Haemost; 2004 Jan; 2(1):200-1. PubMed ID: 14717989
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between soluble thrombomodulin and intercellular adhesion molecule-1 in predicting risk of coronary heart disease.
    Wu KK; Aleksic N; Ballantyne CM; Ahn C; Juneja H; Boerwinkle E
    Circulation; 2003 Apr; 107(13):1729-32. PubMed ID: 12668515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels.
    Li YH; Chen JH; Wu HL; Shi GY; Huang HC; Chao TH; Tsai WC; Tsai LM; Guo HR; Wu WS; Chen ZC
    Am J Cardiol; 2000 Jan; 85(1):8-12. PubMed ID: 11078228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble thrombomodulin as predictor of incident coronary heart disease.
    Salomaa V; Wu KK
    Lancet; 1999 Nov; 354(9190):1646-7. PubMed ID: 10560702
    [No Abstract]   [Full Text] [Related]  

  • 19. Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
    Wuopio J; Hilden J; Bring C; Kastrup J; Sajadieh A; Jensen GB; Kjøller E; Kolmos HJ; Larsson A; Jakobsen JC; Winkel P; Gluud C; Carlsson AC; Ärnlöv J
    Atherosclerosis; 2018 Nov; 278():97-102. PubMed ID: 30261474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
    Folsom AR; Chambless LE; Ballantyne CM; Coresh J; Heiss G; Wu KK; Boerwinkle E; Mosley TH; Sorlie P; Diao G; Sharrett AR
    Arch Intern Med; 2006 Jul; 166(13):1368-73. PubMed ID: 16832001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.